DLA Piper vice chair Loren Brown named to New York Law Journals 2021 Distinguished Leaders list
DLA Piper is pleased to announce that Loren Brown, DLA Piper’s US vice chair and chair of the US Disputes practice, has been named to the New York Law Journal’s 2021 Distinguished Leaders list recognizing lawyers in leadership roles who achieved impressive results over the past year and “had great performances while demonstrating clear leadership skills leading to positive outcomes.”
Brown’s recent successes include a number of complex, multi-district litigations, such as representing Novo Nordisk in its Victoza litigation, Bayer in Essure litigation, Pfizer in Viagra litigation and Bristol Myers Squibb and Pfizer in Eliquis litigation. Brown was also involved in notable counseling work throughout the COVID-19 pandemic, including significant work related to the COVID-19 vaccine and other life-saving therapies.
Brown has an extensive litigation practice with a concentration in multi-district litigation that often involves large-scale mass tort and class action matters, as well as parallel regulatory and government enforcement proceedings. His business litigation practice includes a range of commercial tort and contract, trade secret, intellectual property and securities class action matters. He has served as national coordinating counsel, tried jury cases, argued appeals and successfully resolved many notable multi-district litigation matters throughout the US.
Brown also has significant experience in a range of internal investigation, compliance and regulatory matters, particularly within the life sciences sector, and regularly counsels clients on a wide range of regulatory, risk management, due diligence, product labeling, product recall, public disclosure, policy and crisis management issues.